Talking Urology Podcast
Talking Urology
Add to My Podcasts
Episodes
About
Reviews
Promote
ANZUP 2017 Interviews - David Quinn
16 minutes
Posted Nov 29, 2017 at 7:28 am.
0:00
16:28
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
David Quinn discusses the KEYNOTE-045 trial on the benefits of pembrolizumab in second line treatment of advanced bladder cancer
Previous
ANZUP 2017 Interviews - Peter Black
Next
ANZUP 2017 Interviews - Dennis Taffe
← See all 115 episodes of Talking Urology Podcast
